Research Article

 

Inhibitory Effects of Carvacrol on BlaTEM and Exos Genes Expression in ESβL Producing Pseudomonas aeruginosa Isolated from Kidney Lesions of Broiler Chickens

 

Ismail A. Radwan1, Salama A.S. Shany2, Sara S.E. Amin1, Ahmed H. Abed1*

1Bacteriology, Mycology and Immunology Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt; 2Poultry Diseases Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt.

 

Received | February 16, 2021; Accepted | May 09, 2021; Published | July 28, 2021

*Correspondence | Ahmed H. Abed, Bacteriology, Mycology and Immunology Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt; Email: [email protected], [email protected]

Citation | Radwan IA, Shany SAS, Amin SSE, Abed AH (2021). Inhibitory effects of carvacrol on BlaTEM and Exos genes expression in ESβL producing Pseudomonas aeruginosa isolated from kidney lesions of broiler chickens. Adv. Anim. Vet. Sci. 9(9): 1408-1415.

DOI | http://dx.doi.org/10.17582/journal.aavs/2021/9.9.1408.1415

ISSN (Online) | 2307-8316; ISSN (Print) | 2309-3331

Copyright © 2021 Lukkananukool et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

INTRODUCTION

 

Pseudomonas is a good example of environment-associated infections that causing serious problems in poultry industry because epidemics may spread rapidly through poultry flocks causing mortality in all ages (Satish and Priti, 2015). P. aeruginosa is the most common opportunistic ubiquitous pathogen that often exists in decaying vegetation, soil and water as well as other humid environments (Bakheet and Torra, 2020). P. aeruginosa is a serious avian pathogen as well as zoonotic bacterial agent that can cause nosocomial infections (El-Sayed et al., 2016). The infection may take place via skin wounds, contaminated vaccines, egg inoculation or dipping or via contamination of needles used for injection, and infection can spread between flocks on the same premises under inadequate hygienic conditions (Mohamed, 2004). It can cause respiratory affections, septicemia and other forms in birds (Bakheet and Torra, 2020) inducing a significant economic losses due to high mortality (Elsayed et al., 2016) and can be highly virulent causing 50-100% mortality in experimentally inoculated 4 weeks old chickens (Kebede, 2010).

 

Pseudomonas species have been reported as a cause of bacterial nephritis (Lierz, 2003) which usually occurs after systemic infection and bacteria reach the kidneys through the renal arteries or the renal portal system while ascending infection through the ureters rarely occurs (Ameen et al., 2015).

 

A great problem of P. aeruginosa is its resistance to various antibacterial agents and even newly developed antibiotics have failed to reduce the mortality rate associated with its infection (Ali et al., 2009). The extended spectrum β-lactamases (ESβLs) and plasmid-mediated ampC β-lactamase are essential causes behind the antimicrobial resistance (Carmo et al., 2014). ESβLs production represents high risk in the treatment of pseudomonal infection. ESβLs are widely reported all over the world and have been associated with successful enterobacterial clones having huge epidemic potential (Zahar et al., 2009). ESβLs are plasmid-mediated β-lactamase enzymes that hydrolyze penicillins, narrow spectrum β-lactamas, 3rd and 4th generation cephalosporins and monobactams, meanwhile β-lactamase inhibitors; as clavulanic acid, can inhibit them (Poulou et al., 2014). ESβLs coding plasmids may carry also additional β-lactamase genes and other resistance genes for other antimicrobial classes (Carattoli, 2009). This can restrict the treatment options for ESβL-producing pathogens and enhance the intra- and inter-species spreading of ESβLs (Zahar et al., 2009). Therefore, phenotypic detection of ESβLs within bacteria is essential for epidemiological purposes and restriction of the dissemination of resistance mechanisms. The Clinical and Laboratory Standards Institute recommended a phenotypic confirmatory combined-disc test for ESβL production (CLSI, 2015). It was based on detection of the growth-inhibition zones around both cefotaxime and ceftazidime discs with or without clavulanate (CA). Stuart et al. (2011) have also proposed different combined-disc and double-disc synergy tests depending on the synergy of CA with different expanded spectrum cephalosporins and aztreonam. There are many produced groups of ESβLs but the most commonly existed in clinical Gram-negative isolates are SHV, CTX-M and TEM enzyme types (Bush and Fisher, 2011).

 

P. aeruginosa exoenzyme S (ExoS) is a type III secretion (TTS) effector which has been considered an antiphagocytic virulence factor of P. aeruginosa that enabling it to overcome the host defense mechanism leading to the establishment of infection and tissue damage (Rocha et al., 2003). It catalyzes the transfer of the ADP ribose moiety of NAD+ to many eukaryotic cellular proteins, but its preferred substrates are a subset of the small GTP-binding proteins of 21-25 kDa (Barbieri and Sun, 2004).

 

The spread of drug resistant strains of microorganisms necessitates the discovery of new classes of antibacterial and compounds that inhibits these resistance mechanisms. Bacterial resistance modulators can enhance the activity of an antimicrobial agent against a resistant strain. Such compounds may target a resistance mechanism such as the inhibition of multidrug resistance (MDR) e.g. inhibition of the NorA efflux mechanism or act in a synergistic fashion via an uncharacterized mechanism (Gibbons, 2005). The essential oils (EOs) from many plants are known to possess antimicrobial activity (Radwan et al., 2016). Oregano oil and its major phenolic components carvacrol oil have a wide spectrum of antimicrobial activity (Nostro et al., 2007).

 

The present study was conducted to detect the possible effects of carvacrol oil on blaTEM and exoS genes expression of P. aeruginosa recovered from kidneys of broiler chickens to overcome the drug resistant isolates.

 

MATERIALS AND METHODS

 

Ethical approval

This study was approved from Beni-Suef University, Institutional Animal Care and Use Committee (BSU-IACU/ http://www.bsu.edu.eg).

 

Samples

Eighty kidney samples were collected from diseased broiler chickens aged from 2-4 weeks from different farms in Beni-Suef and El-Fayoum Governorates during the period from January 2019 up to October 2019. These chickens were subjected to postmortem examinations and showed gross pathological kidney lesions. All samples were collected in sterile containers and transferred rapidly in ice box to the laboratory of Bacteriology, Mycology and Immunology Department, Faculty of Veterinary Medicine, Beni-Suef University.

 

Isolation and identification of P. aeruginosa isolates

The collected kidney samples were inoculated under aseptic conditions into tryptone soya broth (Oxoid) and incubated aerobically at 37˚C for 18-24 h. A loopful of broth culture was cultivated onto cetrimide agar and incubated aerobically at 37˚C for 24-72 h. All the recovered isolates were identified morphologically; using Gram’s stain, and biochemically according to schemes described by Quinn et al. (2002). The following tests were used; oxidase, catalase, indole, methyl red, Voges Proskauer, citrate utilization, urease, TSI and sugar oxidation; especially glucose, mannitol and mannose. Other characteristics including pigment production, motility test haemolysis onto blood, growth at 4 and 42ºC and agar were included.

 

Moreover, The Vitek 2 compact system using ID-GN kits was applied on pure cultures for confirmative identification of P. aeruginosa isolates according to BioMérieux (2013).

Phenotypic detection of EsβLS producing isolates (CLSI, 2015)

ESβL production was tested with the CLSI confirmatory test using modified double disc diffusion test by using cefotaxime (CTX, 30 µg), ceftazidime (CAZ, 30 µg), cefepime (FEP, 30 µg) and aztreonam (ATM, 30 µg) discs alone and in combination with amoxicillin-clavulanic (AMC, 30 µg) (Oxoid, Basing Stoke, UK). The discs of CTX, CAZ, FEP and ATM were manually placed around AMC disc with 20 mm center to center and incubated at 37°C for 8 h. The test was regarded as positive when increasing the zone of growth-inhibition around one or more of discs with AMC to 5 mm or more than the diameter around the disc containing them alone.

 

PCR for detection of BLATEM and EXOS genes in P. aeruginosa isolates

PCR was applied on all P. aeruginosa isolates for detection of blaTEM and exoS genes. Genomic DNA was extracted by QIAamp® DNA extraction Mini Kit (Cat. No. 51304 supplied from QIAGEN, USA), according to manufacturer’s instructions. Extracted DNA was kept at -80°C until used in PCR amplification. Oligonucleotide primers sequences as well as amplified products for the targeted genes were illustrated in Table 1. The reaction was performed in a volume of 25 µl consisting of 12.5 µl of 2X PCR master mix, 1µl of each 20 pmol primers, 6µl of DNA extract, and the volume was completed to 25µl using sterile deionized water. The temperature and time conditions of the primers during PCR were shown in Table 2.

 

Detection of minimum inhibitory concentration (MIC) of carvacrol oil against P. aeruginosa isolates using agar dilution method

Different concentrations (800, 400, 200, 100, 50 µl/ml) of carvacrol (Sigma Aldrich, Germany) were prepared and tested for their antibacterial activity against all P. aeruginosa isolates using agar dilution method according to Radwan et al. (2018). Briefly, the tested isolates were grown on tryptone soya agar (TSA) at 37˚C for 24 h, then cells were suspended in physiological saline adjusting the concentration to 1×108 CFU with (equivalent to McFarland standard tube 0.5). TSA was prepared and autoclaved at 121˚C for 15 min. and kept at 55˚C and then the tested oils were dissolved in Dimethyl Sulpho Oxide (DMSO) with a ratio 1:9, sterilized by filtration (pore size 0.45 µm), and mixed with TSA according to the tested concentrations. The oil-agar medium (10 ml) was poured into sterile petri dishes and was solidified. Then, equal amounts of the bacterial suspensions were inoculated and speared onto the agar plates and incubated at 37˚C for 24-48 h.

 

The maximum concentration of carvacrol that did not completely inhibit the bacterial growth was selected for detection of the possible effect on blaTEM and exoS gene expression.

 

Sybr green RT-PCR for BLATEM and EXOS genes before and after carvacrol treatment

SYBR Green RT-PCR was applied for detection of fold changes of blaTEM and exoS genes before and after carvacrol treatment. RNA was extracted by RNeasy Mini Kit (Qiagen Cat. No.74104) according to manufacturer’s instructions. Oligonucleotide primers and probes used in SYBR Green RT-PCR illustrated in Table 1 beside Primers targeting Pseudomonas16S rDNA primers (F: 5’-GACGGGTGAGTAATGCCTA-3’ and R: 5’-CACTGGTGTTCCTTCCTATA-3’ according to Spilker et al. (2004) were used.

 

The reaction was performed in a volume of 25 µl consisting of 12.5 µl of 2X SYBR Green PCR master mix, 0.25 μl reverse transcriptase, 0.5µl of each 20 pmol primers, 3µl of RNA extract, and the volume was completed to 25µl using sterile RNase free water. The temperature and time conditions of the primers during SYBR green RT-PCR were shown in Table 3. Analysis of the SYBR green RT-PCR results was according to the “ΔΔCt” method stated by Yuan et al. (2006).

 

Table 1: Primers of blaTEM and exoS genes used in cPCR and SYBR Green RT-PCR.

 

Primer	Amplified product	Primer sequence (5'-3')		Reference
blaTEM	516 bp	ATCAGCAATAAACCAGC CCCCGAAGAACGTTTTC	F R	Colom et al. (2003)
exoS	118 bp	GCGAGGTCAGCAGAGTATCG TTCGGCGTCACTGTGGATGC	F R	Winstanley et al. (2005)

 

Table 2: Cycling conditions of the different primers during PCR.

 

Gene	Primary denaturing	Secondary denaturing	Annealing	Extension	No. of cycles	Final extension
blaTEM	94˚C/5 min	94˚C/30sec.	54˚C/40sec.	72˚C/45sec.	35cycles	72˚C/10min.
exoS	94˚C/5min.	94˚C/30sec.	55˚C/30sec.	72˚C/30sec.	35cycles	72˚C/7min.

Table 3: Cycling conditions for SYBR green RT-PCR.

 

Target gene	Reverse transcription	Primary denatu ration	Amplification (40 cycles)			Dissociation curve (1 cycle)
			Secondary denaturation	Annealing (Optics on)	Extension	Secondary denaturation	Annealing	Final denat uration
Pseudomonas 16S rDNA	50˚C/ 30min	94˚C/ 15min	94˚C/15sec.	50˚C/40sec.	72˚C/ 40sec	94˚C/1min	54˚C/1min	94˚C /1min
blaTEM				54˚C/40sec.			54˚C/1min
exoS				55˚C/30sec.			55˚C/1min

 

Table 4: RT-PCR for P. aeruginosa isolates before and after treatment with carvacrol oil.

 

Sample No.	Type	Sample (ID)	16S rDNA	blaTEM		exoS
			CT	CT	Fold change	CT	Fold change
1	Control	2	20.73	21.19	-	20.55	-
	Treated	2A	20.82	21.61	0. 7955	21.08	0.7371
2	Control	3	20.51	22.05	-	21.10	-
	Treated	3A	20.74	22.91	0.6462	22.12	0.5783

 

RESULTS AND DISCUSSION

 

Prevalence of ESβLS producing P. aeruginosa isolation from cases kidney lesions in broiler chickens

Out of 80 kidney samples from diseased broiler chickens, 6 P. aeruginosa isolates (7.5%) were recovered. Phenotypic detection of ESβLs producing P. aeruginosa isolates; using modified CLSI ESβLs confirmatory test, revealed that 4 isolates (66.7%) were ESβLs producers.

 

PCR OF P. aeruginosa isolates for detection of BLATEM and EXOS genes

PCR results revealed that out of 6 examined P. aeruginosa isolates, blaTEM was positive only in 4 isolates (66.7%) those were confirmed phenotypically as ESβLs producers while the other 2 negative ESβLs producers isolates didn`t exist blaTEM gene (Figure 1). Meanwhile, exoS gene was positive in all isolates (n=6, 100%) (Figure 2).

 

Detection of mic of carvacrol against P. aeruginosa isolates

Carvacrol oil completely inhibited the growth of the tested P. aeruginosa isolates at concentrations of 800, 400 and 200 µl/ml. Meanwhile, at concentrations of 100 and 50 µl/ml, the growth of 4 (66.7%) and 2 (33.3%) isolates were inhibited, respectively.

 

Sybr green RT-PCR for BLATEM AND EXOS genes in P. aeruginosa isolates before and after treatment with carvacrol

The quantitative RT-PCR (qRT-PCR) was applied on the two P. aeruginosa isolates; those not inhibited with carvacrol treatment at concentration of 100 µl/ml, for detection of possible fold changes of blaTEM and exoS genes expression after treatment with carvacrol. The results were illustrated in Table 4 and Figures 3, 4 and 5).

 

 

Regarding blaTEM gene, the results of qRT-PCR showed that the fold changes in the two P. aeruginosa isolates after treatment were 0.7955 and 0.6462 indicating mild reduction in the blaTEM gene expression after carvacrol treatment to 0.8 and 0.6 folds, respectively (Table 4 and Figure 4). Meanwhile, the fold changes of exoS gene after carvacrol treatment were 0.7371 and 0.5783, indicating also mild reduction in exoS gene expression to 0.7 and 0.6 folds, respectively (Table 4 and Figure 5).

 

Pseudomonas aeruginosa is a good example of ubiquitous opportunistic environmental pathogens; found in soil, water, feed and farm equipment, causing serious problems in poultry farms including respiratory infections, septicaemia and other forms when introduced into tissues of susceptible birds (Bakheet and Torra, 2020) resulting in significant economic losses due to high mortalities in all ages (Satish and Priti, 2015). Therefore, application of sanitary measures should be taken in considerations in the poultry husbandry especially feeds and water supply. Outbreaks of P. aeruginosa infection may cause mortality rate that reach 20-90% (Shukla and Mishra, 2015). High mortalities of P. aeruginosa infections are due to the existence of different virulence factors, innate and acquired MDR as well as immune compressed hosts (Poole, 2011).

 

 

 

In this study, the prevalence of P. aeruginosa isolation from kidney lesions in broiler chickens was 7.5%. This result was supported with that obtained by Al-Hiyali et al. (2005) in Iraq, who studied 80 broiler chickens cases of damaged kidney and isolated P. aeruginosa from 14 cases with a percentage of 17.5%. Other studies reported P. aeruginosa as a cause of bacterial nephritis (Lierz, 2003; Satish and Priti, 2015). It can reach the kidney via circulation secondary to systemic disease and rarely can ascend the ureters (Ameen et al., 2015).

 

 

 

Treatment of infections caused by P. aeruginosa is difficult since it has high resistance to various antimicrobials (Ali et al., 2009). ESβLs are plasmid-mediated β-lactamases that hydrolyze cephalosporins and monobactams with an oxyimino side chain while they can be inhibited by β-lactamase inhibitors; as clavulanic acid, (Fisher, 2011). CLSI recommended a phenotypic confirmatory combined-disc test for detection of ESβL production (CLSI, 2015).

 

In our study, ESβLs producing P. aeruginosa isolates from kidney lesions were phenotypically detected using modified CLSI ESβLs confirmatory test and 66.7% of examined isolates were confirmed as ESβLs producers. Much lower results were previously recorded (Umadevi et al., 2011; 19.4%, (Rafiee et al., 2014); 6.5% of human isolates from burns, (Zafer et al., 2014); 7.4% among isolates from cancer patients; (Shaikh et al., 2015); 25.1% of isolates using double disc synergy test. Moreover, Begum et al. (2013) noticed ESβLs production in 35.4 % of the examined Pseudomonas aeruginosa isolates by double disc diffusion method using AMC with CAZ, CTX, ceftriaxone and ATM.

 

The emergence and spreading of β-lactam resistance in nosocomial P. aeruginosa and Enterobacteriaceae became a serious problem particularly the increased resistance against carbapenems and 3rd and 4th generation cephalosporins (Pfeifer et al., 2010). ESβLs are of the main causes of β-lactam resistance among Gram-negative bacteria (Rawat and Nair, 2010). P. aeruginosa pursue multiple molecular mechanisms for emerging the resistance to these antibiotics; (a) ESβL generation, (b) acquiring the ESβL encoding genes as SHV, CTX-M and TEM β-lactamases from environmental bacteria, (c) increasing the chromosome-encoded β-lactamase genes (bla) expression, (d) movement of bla genes by fusion with integrons and horizontal transferring into other Gram-negative bacteria, (e) spreading of plasmid-mediated carbapenemases (such as metallo-β-lactamases and KPC), (f) stop porin genes expression and/or efflux pump-based antibiotic resistance (Pfeifer et al., 2010).

 

ExoS is a virulence factor of P. aeruginosa having an antiphagocytic activity allowing the bacteria to overcome the host immunity and consequently establishment of infection and damage of tissues (Rocha et al., 2003). ExoS and other exotoxins share in tolerance of the innate immune responses and possess enzymatic activities that leading to disturbance in host cells physiology preventing bacterial clearance. Presence of substrate targets and co-factors in the eukaryotic cells are responsible for these effectors activation giving specificity to these toxins in the eukaryotic cells (Stato et al., 2006).

 

In this study, PCR was conducted on all P. aeruginosa isolates (n=6) for detection for blaTEM and exoS genes. Results revealed the existence of blaTEM in isolates confirmed phenotypically as ESβLs producers only (n=4; 66.7%) while others non- ESβLs producers were negative for blaTEM gene. These results were coincided with that considering ESβLs as of the major causes of β-lactam resistance among Gram-negative bacteria (Rawat and Nair, 2010) and that considering TEM enzyme type as of the most commonly existed ESβLs in clinical isolates (Bush and Fisher, 2011).

 

Meanwhile, exoS gene was existed in all isolates (100%). Different percentages of exoS gene were reported in previous studies; Zhao et al. (2012) detected exoS in 58% of examined P. aeruginosa isolates, Tartor and El-Naenaeey (2016) reported that 79% of P. aeruginosa isolates expressed exoS which was found in more virulent strains and Benie et al. (2017) detected exoS in 89% of P. aeruginosa isolates.

 

Since ancient times, the antimicrobial impact of Eos and their components extracted from aromatic and medicinal plants, both on health and food preservation have been recognized (Radwan et al., 2018). Moreover, EOs from many plants are known to possess antimicrobial activity (Radwan et al., 2016). The antimicrobial actions of EOs are associated with their hydrophobicity leading to increase the cell permeability and consequently leakage of cell components (Lambert et al., 2007). The concept of using a compound that inhibits resistance in a bacterium, which may be employed with a conventional antibiotic, was well proven (Gibbons, 2005).

 

In our study, carvacrol oil was tested for its antibacterial activity against P. aeruginosa isolates at concentrations of 800, 400, 200, 100 and 50 µl/ml for detection of MIC against P. aeruginosa isolates. Complete growth inhibition of the tested isolates was recorded at concentrations of 800, 400 and 200µl/ml. Therefore, the MIC of carvacrol against P. aeruginosa isolates was 200µl/ml. Meanwhile, 100 and 50µl/ml concentrations inhibited the growth of 66.7% and 33.3% of isolates, respectively. Such results supported those reported by Al-Sayed (2017) who studied the antibacterial effect of carvacrol oil on P. aeruginosa and recorded complete growth inhibition at concentration of 1% while concentration of 0.1% inhibited 73.3% of the tested isolates. On the same context, Radwan et al. (2016) studied the antibacterial effect of oreganium EO on E. coli and recorded complete bacterial growth inhibition at concentrations of 1% and 0.5%.

 

In the present study, the two P. aeruginosa isolates which not inhibited with treatment with carvacrol at concentration of 100 µl/ml was selected for detection of the possible effect on blaTEM and exoS gene expression using qRT-PCR after carvacrol treatment. The qRT-PCR results indicated mild reduction of the blaTEM and exoS genes expression after carvacrol treatment to 0.6-0.8 folds.

 

Carvacrol is the bioactive lipophilic and phenolic component; representing the major constituent of thyme and oregano EOs comprising 86.5 %, having high inhibitory activity against various pathogens (Bharti et al., 2013). The antibacterial activity of carvacrol was attributed to disintegration of the outer membrane of Gram-negative bacteria releasing LPS and enhancing the cytoplasmic membrane permeability to ATP (Burt, 2004). Carvacrol has been suggested to occupy more area than the typical space between the fatty acid chains of two adjacent phospholipid molecules interfering with the van der Waals interactions between the chains expanding the liposomal membrane using fluorescent probes and consequently affects fluidity (Ultee et al., 2002).

 

CONCLUSIONS AND RECOMMENDATIONS

 

Pseudomonas aeruginosa is an opportunistic environmental pathogen causing serious problems in poultry farms. The prevalence of P. aeruginosa in the examined kidney samples of broiler chickens was 7.5%. Most of isolates (66.7%) were ESβLs producer harboring both blaTEM and exoS genes. Carvacrol oil treatment showed an antimicrobial activity against the isolates with a MIC of 100µl/ml and induced mild reduction of the blaTEM and exoS genes expression after carvacrol treatment. Therefore, carvacrol and other EOs could be used as alternatives for synthetic antimicrobial drugs.

 

ACKNOWLEDGMENTS

 

The authors would like to thank the Bacteriology, Mycology and Immunology Department staff at the Faculty of Veterinary Medicine, Beni-Suef University for providing technical help.

 

Novelty Statement

 

The present work studied the antibacterial effect of carvacrol oil on ESβL Producing Pseudomonas aeruginosa isolated from kidney lesions of broiler chickens and detecting its inhibitory effects on the blaTEM and exoS genes expression in P. aeruginosa isolates.

 

AUTHOR’S CONTRIBUTION

 

Idea and Conceptualization, IAR and AHA; Sample collection, AHA, SSEA and SASS; Methodology and data analysis IAR, AHA, SASS and SSEA; Original draft preparation, AHA and SASS; Reviewing and editing, IAR, AHA, SASS and SSEA.

 

Conflict of interest

 

The authors have declared no conflict of interest.

 

REFERENCES

 

• Al-Hiyali HM, Al-Kabbi HT, Abdulkarim S (2005). Isolation of four types of bacteria that cause kidney damage in broiler chickens. Iraqi J. Vet. Med. 29(1): 33-42. https://doi.org/10.30539/iraqijvm.v29i1.860

• Ali M, Jamshid K, Davood M, Aziz J, Masoud A, Mohsen N, Ahmed H, Nazanin K (2009). Active immunization using exotoxin A confers protection against P. aeruginosa infecti https://doi.org/10.1186/1471-2180-9-23 on in a mouse bum model. BMC Microbiol., pp. 9-23.

• Al-Sayed MAY (2017). Phenotypic and genotypic characterization of Gram negative oxidase positive bacilli in chickens. Ph. D. thesis (Microbiology), Fact. Vet. Med., Beni-Suef Univ., Egypt.

• Ameen NA, Aref ED, Al-Obaidi RM, Raoof HH (2015). Isolation and identification of bacteria from kidney lesions in broilers in Sulaimania province. Assiut. Vet. Med. J., 61(145): 8-11. https://doi.org/10.21608/avmj.2015.169750

• Bakheet AA, Torra DE (2020). Detection of Pseudomonas aeruginosa in dead chicken embryo with reference to pathological changes and virulence genes. Alex. J. Vet. Sci., 65(1): 81-89. https://doi.org/10.5455/ajvs.101343

• Barbieri JT, Sun T (2004). Pseudomonas aeruginosa exoS and exoT. Physiol. Biochem. Pharmacol., 152: 79-92. https://doi.org/10.1007/s10254-004-0031-7

• Begum S, Salam MA, Alam KF, Begum N, Hassan P, Haq JA (2013). Detection of extended spectrum B-lactamase in Pseudomonas species isolated from two tertiary care hospitals in Bangladesh. BMC Res. Notes, 6: 7. https://doi.org/10.1186/1756-0500-6-7

• Benie CKD, Dadie A, Guessennd N, Kouame ND, Kouadio NAN, Aka S, DJE KM, Dosso M (2017). Molecular identification and virulence factors of Pseudomonas aeruginosa strains isolated from animal products. J. Bacteriol. Mycol., 4(3): 00094.

• Bharti V, Vasudeva N, Sharma S, Duhan JS (2013). Antibacterial activities of Origanum vulgare alone and in combination with different antimicrobials against clinical isolates of Salmonella typhi. Anc. Sci. Life, 32(4): 212-216. https://doi.org/10.4103/0257-7941.131974

• BioMérieux Vitek, Inc. 04/ (2013). Vitek2-technology product information manual. Pdf version located with the QC SOPs, a hard copy is available in the laboratory. 4.

• Burt SA (2004). Antibacterial activity of essential oils: Potential applications in food. Ph.D. Thesis. Institute for Risk Assessment Sciences, Division of Veterinary Public Health Utrecht University.

• Bush K, Fisher JF (2011). Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from Gram-negative bacteria. Annu. Rev. Microbiol., 65: 455-478. https://doi.org/10.1146/annurev-micro-090110-102911

• Carattoli A (2009). Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother., 53: 2227-2238. https://doi.org/10.1128/AAC.01707-08

• Carmo LP, Neilsen LR, da Costa PM, Alban L (2014). Exposure assessment of extended-spectrum beta-lactamases AmpC beta-lactamases producing E. coli in meat in Denmark. Infect. Ecol. Epidmiol., 4: 22924. https://doi.org/10.3402/iee.v4.22924

• Clinical and Laboratory Standards Institute (CLSI) (2015). Performance standards for antimicrobial susceptibility testing. Twenty fifth informational supplement update. CLSI document M 100-S25. Clinical and Laboratory Standards Institute. Wayne, PA.

• Colom K, Pèrez J, Alonso R, Fernández-Aranguiz A, Lariňo E, Cisterna R (2003). Simple and reliable multiplex PCR assay for detection of blaTEM, blaSHV and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiol. Lett., 223: 147-151. https://doi.org/10.1016/S0378-1097(03)00306-9

• El-Sayed MSA, Ammar AM, Al shehri ZS, Abd-El Rahman H, Abd-ElRahman NA (2016). Virulence repertoire of Pseudomonas aeruginosa from some poultry farms with detection of resistance to various antimicrobials and plant extracts. Cell Mol. Biol., 62: 124.

• Fisher BK (2011). Epidemiological expansion, structural studies, and clinical challenges of new β-Lactamases from Gram negative bacteria. Annu. Rev. Microbiol., 65: 455-478 https://doi.org/10.1146/annurev-micro-090110-102911.

• Gibbons S (2005). Plants as a source of bacterial resistance modulators and anti-infective agents. Phytochem. Rev., 4: 63-78. https://doi.org/10.1007/s11101-005-2494-9

• Kebede F (2010). Pseudomonas infection in chicken. J. Vet. Med. Anim. Health, 2(4): 55-58.

• Lambert RJW, Skandamis PN, Coote PJ, Nychas GJE (2007). A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J. Appl. Microbiol., 91: 453-462. https://doi.org/10.1046/j.1365-2672.2001.01428.x

• Lierz M (2003). Avian renal disease: pathogenesis, diagnosis, and therapy. Vet. Clin. N. Am. Exotic. Am. Pract., 6: 29-55. https://doi.org/10.1016/S1094-9194(02)00029-4

• Mohamed HA (2004). Some studies on Pseudomonas species in chicken Embryos and broilers in Assiut Governorate. Ass. Univ. Bull. Environ. Res., 7(1): 23-30. https://doi.org/10.21608/auber.2004.150590

• Nostro A, Roccaro AS, Bisignano G, Marino A, Cannatelli MA, Pizzimenti FC, Cioni PL, Procopio F, Blanco AR (2007). Effect of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Med. Microbiol., 56: 519-523. https://doi.org/10.1099/jmm.0.46804-0

• Pfeifer Y, Cullik A, Witte W (2010). Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int. J. Med. Microbiol., 300(6): 371-379. https://doi.org/10.1016/j.ijmm.2010.04.005

• Poole K (2011). Pseudomonas aeruginosa: Resistance to the max. Front. Microbiol., 2: 65. https://doi.org/10.3389/fmicb.2011.00065

• Poulou A, Grivakou E, Vrioni G, Koumaki V, Pittaras T, Pournaras S, Tsakris A (2014). Modified CLSI Extended spectrum β-Lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β. Lactamases. J. Clinc. Microbio., 52(5): 1483–1489. https://doi.org/10.1128/JCM.03361-13

• Quinn PJ, Markey BK, Carter ME, Donnelly WJC, Leonard FC, Maguire D (2002). Veterinary microbiology and microbial disease. Published by Blackwell. pp. 113-116.

• Radwan IA, Abed AH, Abdallah AS (2018). Antifungal effect of carvacrol on fungal pathogens isolated from broiler chickens. Assiut. Vet. Med. J., 64(157): 11-17. https://doi.org/10.21608/avmj.2018.168896

• Radwan IA, Abed AH, Abd Al-Wanis SA, Abd El-Aziz GG, El-Shemy A (2016). Antibacterial effect of cinnamon and oreganium oils on multidrug resistant Escherichia coli and Salmonellae isolated from broiler chickens. J. Egyp. Vet. Med, Ass., 76(2): 169-186.

• Rafiee R, Eftekhar F, Tabatabaei SA, Tehrani MD (2014). Prevalence of extended-spectrum and metallo β-lactamase production in AmpC β-lactamase producing Pseudomonas aeruginosa isolates from burns. Jandishapur J. Microbiol., 7(9): e16436. https://doi.org/10.5812/jjm.16436

• Rawat D, Nair D (2010). Extended-spectrum beta-lactamases in Gram Negative Bacteria. J. Glob. Infect. Dis., 2: 263-274. https://doi.org/10.4103/0974-777X.68531

• Rocha CL, Coburn J, Rucks EA, Olson JC (2003). Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect. Immun., 71(9): 5296-5305. https://doi.org/10.1128/IAI.71.9.5296-5305.2003

• Satish S, Priti M (2015). Pseudomonas aeruginosa infection in broiler chicks in Jabalpur. Int. J. Ext. Res., 6: 37-39.

• Shaikh S, Fatima J, Shakil S (2015). Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital. Saudi J. Biol. Sci., 22(1): 62-64. https://doi.org/10.1016/j.sjbs.2014.06.001

• Shukla S, Mishra P (2015). Pseudomonas aeruginosa infection in broiler chicks in Jabalpur. Int. J. Ext. Res., 6: 37-39.

• Spilker T, Coenye T, Vandamme P, LiPuma JJ (2004). PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J. Clin. Microbiol., pp. 2074-2079. https://doi.org/10.1128/JCM.42.5.2074-2079.2004

• Stato H, Feix JB, Frank DW (2006). Identification of superoxide dismutase as a cofactor for the Pseudomonas type toxin, Exo U. Biochemistry, 45(34): 10368-103750. https://doi.org/10.1021/bi060788j

• Stuart JC, Diederen B, Al Naiemi N, Fluit A, Arents N, Thijsen S., Vlaminckx B, Mouton JW, Leverstein-van Hall M (2011). Method for phenotypic detection of extended-spectrum β-lactamases in Enterobacter species in the routine clinical setting. J. Clin. Microbiol., 49: 2711-2713. https://doi.org/10.1128/JCM.00864-11

• Tartor YH, El-Naenaeey EY (2016). RT-PCR detection of exogenes expression in multidrug resistant P. aeruginosa. Cell Mol. Biol. (Noisy-le-grand). 22: 62(1): 56-62.

• Ultee A, Bennink MHJ, Moezelaar R (2002). The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl. Environ. Microbiol., 68: 1561-1568. https://doi.org/10.1128/AEM.68.4.1561-1568.2002

• Umadevi S, Joseph NM, Kumari K, Easow JM, Kumar S, Stephen S, Srirangaraj S, Raj S (2011). Detection of extended spectrum β-lactamases, AmpC beta lactamases and metallo-betalactamases in clinical isolates of ceftazidime resistant Pseudomonas aeruginosa. Braz. J. Microbiol. 42: 1284-1288. https://doi.org/10.1590/S1517-83822011000400006

• Winstanley C, Kaye SB, Neal TJ, Chilton HJ, Miksch S, Hart CA, The Microbiology Ophthalmic Group (2005). Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J. Med. Microbiol., 54: 519-526. https://doi.org/10.1099/jmm.0.46005-0

• Yuan JS, Reed A, Chen F, Stewart CN (2006). Statistical analysis of real-time PCR data. BMC Bioinformatics, 7: 85. https://doi.org/10.1016/j.csda.2005.11.017

• Zafer MM, Al-Agamy MH, El-Mahallawy HA, Amin MA, Ashour MS (2014). Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed. Res. Int., pp. 101635-101635. https://doi.org/10.1155/2014/101635

• Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P (2009). Addressing the challenge of extended-spectrum β-lactamases. Curr. Opin. Investig. Drugs, 10: 172-180.

• Zhao RZ, Zheng YJ, Chen Q (2012). Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection Zhonghua Er Ke Za Zhi., 50(9): 672-677.